A primary focus of neurointensive care is monitoring the injured brain to detect harmful events that can impair cerebral blood flow ͑CBF͒, resulting in further injury. Since current noninvasive methods used in the clinic can only assess blood flow indirectly, the goal of this research is to develop an optical technique for measuring absolute CBF. A time-resolved near-infrared ͑TR-NIR͒ apparatus is built and CBF is determined by a bolus-tracking method using indocyanine green as an intravascular flow tracer. As a first step in the validation of this technique, CBF is measured in newborn piglets to avoid signal contamination from extracerebral tissue. Measurements are acquired under three conditions: normocapnia, hypercapnia, and following carotid occlusion. For comparison, CBF is concurrently measured by a previously developed continuous-wave NIR method. A strong correlation between CBF measurements from the two techniques is revealed with a slope of 0.79± 0.06, an intercept of −2.2± 2.5 ml/ 100 g / min, and an R 2 of 0.810± 0.088. Results demonstrate that TR-NIR can measure CBF with reasonable accuracy and is sensitive to flow changes. The discrepancy between the two methods at higher CBF could be caused by differences in depth sensitivities between continuous-wave and time-resolved measurements. © 2010 Society of Photo-Optical Instrumentation Engineers.
Introduction
The goal of neurointensive care is to provide an optimal environment for recovery from life-threatening neurological emergencies such as stroke, traumatic brain injury, and subarachnoid hemorrhage. 1, 2 Owing to the brain's high energy demands and limited substrate storage, one of the primary concerns is preventing secondary cerebral ischemia due to systemic ͑hypotension and hypocapnia͒ or intracranial ͑edema, hypertension, and impaired autoregulation͒ factors. This focus has led to the recognition that a monitoring device capable of detecting cerebral ischemia would greatly enhance the management of neurological emergencies.
Techniques for measuring cerebral blood flow ͑CBF͒ using clinical imaging modalities, e.g., computed tomography ͑CT͒ and magnetic resonance imaging ͑MRI͒, have been developed, but the need to transfer critically ill patients to imaging facilities and prolonged scanning times seriously impede their use in the management of intensive care patients. 3 The primary clinical method for bedside blood flow monitoring is transcranial Doppler ͑TCD͒, which measures mean flow velocities in cerebral arteries. However, the accuracy of TCD is highly operator dependent, the signal is not found in 10 to 30% of patients, and the technique cannot measure blood flow in the microvasculature, which can be different from flow in major arteries. 4 Cerebral blood flow can be measured directly using laser Doppler or thermal diffusion flowmetry, 5, 6 but these techniques are invasive, requiring insertion of probes directly into tissue, and they can only measure CBF in the small volume where the probes are placed. Wider applicability requires noninvasive techniques that can assess CBF in multiple regions.
Optical methods are promising alternatives to current invasive techniques, since they are safe, portable, and provide measurements of tissue oxygenation and hemodynamics. 7, 8 Our group has developed a continuous-wave ͑CW͒, nearinfrared spectroscopy ͑NIRS͒ technique for measuring CBF in newborns. [9] [10] [11] The technique is based on bolus-tracking theory 12 and uses the near-infrared light absorbing dye indocyanine green ͑ICG͒ as an intravascular contrast agent. The major challenge in adapting our ICG bolus-tracking technique to adult patients is the sizable signal contamination from superficial tissue. It has been previously reported that the ICG bolus-tracking method combined with CW-NIRS underestimates CBF in adults by a factor of 3 due primarily to the overestimation of the optical path length through brain tissue. 13, 14 Improved depth sensitivity has been achieved using photon time-of-flight information measured directly by time-resolved ͑TR͒ techniques, or indirectly through phase changes measured by frequency-domain ͑FD͒ techniques. [15] [16] [17] [18] The depth sensitivity made available by these techniques is due to the fact that early arriving photons travel shorter distances ͑i.e., through superficial tissue͒, while late arriving photons travel longer distances ͑i.e., deeper into brain tissue͒. Both approaches have been used to extract first-pass kinetics of ICG through the brain in adults. 19, 20 Although promising, these studies were qualitative and did not attempt to determine absolute CBF. The ultimate goal of our research is to measure CBF in critical-care patients by adapting our quantitative ICG bolus-tracking method to TR reflectance measurements. A time-correlated single-photon counting system was assembled and, as a first step, we investigated the ability of the system to measure CBF over a range of values in piglets. Piglets were chosen to avoid signal contamination from extracerebral tissue, which enabled TR reflectance data to be modeled by the solution to the diffusion equation for a homogeneous semiinfinite geometry. 21 Absolute concentration of ICG in brainrequired to measure CBF-was determined from the change in the absorption coefficient. For comparison, CBF was concurrently measured using our previously developed CW system.
Materials and Methods

Instrumentation
The light source of the TR system consisted of a picosecond pulsed diode laser ͑LDH-P-C-810, PicoQuant, Germany͒ emitting at 802 nm, which coincides with the peak absorption wavelength of ICG in plasma, and a computer-controlled laser driver ͑PDL 828, PicoQuant͒. The laser output power and pulse repetition rate were set to 1.4 mW and 80 MHz, respectively. The laser output was coupled by a microscope objective lens ͑NA= 0.25, magnification= 10ϫ͒ into a 1.5-m-long multimode fiber probe ͑NA= 0.22, core 400 m, 4.7-mm outer diameter; Fiberoptics Technology, Pomfret, Connecticut͒ mounted on a custom-made holder. The average power delivered to a sample was attenuated to roughly 20 W using two variable neutral density filters ͑NDC-50-4M, Thorlabs, Newton, New Jersey͒.
Diffusely reflected light from the sample was collected by a 2-m fiber optic bundle ͑NA= 0.55, 3.6-mm-diameter active area, and 4.7-mm outer diameter, Fiberoptics Technology͒ whose distal end was secured in front of an electromechanical shutter ͑SM05, Thorlabs͒. Light transmitted through the shutter was collected by a Peltier-cooled photomultiplier tube ͑PMT͒ ͑PMC-100, Becker and Hickl, Germany͒. Detection of single photons generated electrical pulses ͑amplitude of 50 to 200 mV, width= 1.5 ns͒ that were transmitted to a time-correlated single photon counting ͑TCSPC͒ module ͑SPC-134, Becker and Hickl, Germany͒. The TCSPC module had a dead-time of 100 ns, and because of that, the maximum count rate was constrained to approximately 800 kHz ͑i.e., one electron detected every 1.25 s͒ to minimize dead-time effects. This count rate, which was 1% of the laser pulse repetition rate, also minimized pile-up effects. 22 To accurately quantify optical properties, the instrument response function ͑IRF͒ was measured to account for dispersion by the TR system. 23 The IRF was measured by placing a thin piece of white paper between the emission fiber and the detection fiber bundle. The paper was coated with black toner to reduce back-reflection from the emission fiber. 24, 25 These measurements were acquired at the start of each animal experiment ͑described in Sec. 2.7͒ and at the same count rate ͑800 kHz͒.
The CW broadband near-infrared apparatus has been described in detail elsewhere. 9, 10 Briefly, the illumination unit was a 50-W halogen light bulb, bandpass filtered from 600 to 1000 nm. The emission and detection fiber optic bundles had a length of 2 m, an NA of 0.55, a 3.6-mm-diameter active area, and 4.7-mm outer diameter. The spectrometer consisted of a holographic grating housed in a light-tight box, which was coupled to a cooled chargecoupled device ͑CCD͒ camera ͑Wright Instruments, Middlesex, United Kingdom͒.
Bolus-Tracking Method
The hemodynamics of an organ can be characterized by tracking the passage of a bolus of contrast agent, in this case ICG, through the vascular bed. 12 As such, the time-dependent concentration of ICG in tissue Q͑t͒ is related to the ICG concentration in arterial blood C a ͑t͒ by the following expression:
In Eq. ͑1͒, R͑t͒ is referred to as the impulse residue function, which represents the tissue ICG concentration for the idealized case that the input function CBF· C a ͑t͒ is defined by a dirac-delta function with unit mass deposited at time zero. A necessary assumption is that blood flow remains constant during the bolus-tracking experiment, which typically lasts about 40 s. In the general case, ICG is injected in a peripheral vein, Q͑t͒ is measured by a NIR technique, and C a ͑t͒ is measured noninvasively by a dye densitometer ͑DDG 2001, Nihon Kohden, Japan͒. The function CBF· R͑t͒ is extracted from the arterial and tissue ICG concentration curves using a deconvo-lution algorithm. 9 The initial height of the derived function is CBF, and the area under the curve is the cerebral blood volume ͑CBV͒. 
Continuous-Wave Measurement of Q͑t͒
For the CW-NIRS experiments, the modified Beer-Lambert law was used to determine Q͑t͒ from the change in the light attenuation spectrum ⌬A͑ , t͒:
where ICG ͑͒ is the extinction coefficient spectrum of ICG, and DP is the differential path length. 26 The latter was determined from the 840-nm water feature, using secondderivative spectroscopy to remove the effects of light scatter, and assuming a water concentration in brain of 85%. 27 
Time-Resolved Measurement of Q͑t͒
Quantification of the optical properties ͑i.e., the absorption coefficient a and the reduced scattering coefficient s Ј͒ was obtained using the solution to the diffusion equation for a homogeneous semi-infinite medium. 21 The model solution was first convolved with the measured IRF, and then a nonlinear optimization routine ͑MATLAB function fminsearch͒ was used to fit the convolved model to each measured temporal point spread function ͑TPSF͒. The fitting range was set to 80% of the peak value on the leading edge and 20% on the falling edge. 28 Determining the tissue ICG concentration first required measuring the baseline optical properties ͑ a and s Ј͒ from the TPSFs collected over a 10-s period prior to an ICG injection. The fitting procedure included an additional scaling factor to account for the laser power, detection gain, and coupling efficiency. 23 The change in light absorption caused by ICG was then characterized using only a as a fitting parameter, with s Ј and the scaling factor fixed to their baseline values. Finally, the measured change in the absorption coefficient ͑ a ͒ was used to calculate ICG concentration by:
where a ͑0͒ represents the baseline value determined prior to the injection of ICG, and ICG is the extinction coefficient of ICG at 802 nm ͑186 OD/ mM/ cm 29 ͒. For comparison with the second-derivative, water-based measurements of DP, the differential path length was calculated from the difference between the mean transit times of the experimental TPSF and the IRF. 30 A refractive index of 1.4 was used to convert the mean transit time measurements to DP. 31 
Time-Resolved Error Analysis
A number of potential sources of error can reduce the accuracy of TR measurements, including improper characterization of instrument dispersion, timing uncertainties, and potential nonlinearities of the TCSPC system. 23 The importance of these factors was assessed by determining how an error in each altered the expected change in a corresponding to the difference between peak and baseline tissue ICG concentrations, denoted ⌬ a max . We focused on ⌬ a max , since the tissue concentration of ICG is directly proportional to CBF ͓Eq. ͑1͔͒. Two simulated TPSFs were generated from the homogeneous analytical model using typical baseline a and s Ј values ͑0.150 cm −1 and 7.4 cm −1 ͒ and ⌬ a max = 0.045 cm −1 . The TPSFs were convolved with an IRF with a systematic error. These data were reanalyzed using the true IRF to determine the best-fit estimate of ⌬ a max , which was then compared to the known value.
First, errors caused by instrument dispersion were assessed by changing the full width at half maximum ͑FWHM͒ of the measured IRF ͑ Ϯ 20%͒. Second, errors caused by timing uncertainties were assessed by shifting the position of the IRF by Ϯ21 ps, which was approximately five times larger than the uncertainty in position ͑4.3 ps͒. 32 Finally, potential distortions in the shape of the TPSF caused by nonlinearities were characterized using two IRFs: one acquired at the baseline count rate of 800 kHz and another acquired at 400 kHz, which corresponds to the maximum decrease following an injection of ICG. The TPSF representing baseline ICG concentration was convolved with the IRF measured at 800 kHz, and the TPSF corresponding to the peak tissue ICG concentration was convolved with the IRF measured at 400 kHz.
Time-Resolved Phantom Experiments
To test the accuracy of the TR system, the optical properties of a tissue-mimicking phantom ͑ISS, Champaign, Illinois͒ were measured. Thirty-two TPSFs with an integration time of 400 ms were acquired. The known a and s Ј values provided by the manufacturer were 0.103 and 10.6 cm −1 at 690 nm, and 0.101 and 9.6 cm −1 at 830 nm, respectively.
Animal Experiments
All animal experiments were approved by the Animal Use Subcommittee of the Canadian Council on Animal Care at the University of Western Ontario. Duroc-cross piglets were delivered from a local supplier on the morning of the experiment. Piglets were anesthetized with 1.75% isoflurane ͑3% during surgery͒, tracheotomized, and mechanically ventilated on an oxygen/medical air mixture. An ear vein was catheterized for ICG ͑Sigma-Aldrich, Saint Louis, Missouri͒ injections, and a femoral artery was catheterized to monitor blood pressure and intermittently collect blood samples for gas and glucose analysis. Two incisions were made lateral to the trachea, and vascular occluders ͑1.5 mm inner diameter, In Vivo Metric, Healdberg, California͒ were placed around both carotid arteries proximal to the carotid bifurcation. The occluders were used to temporarily create conditions of cerebral ischemia. 33 Animals were placed in a prone position, and a custom-made probe holder was strapped to the head to hold the emission and detection probes 2.7 cm apart, parasagittally, approximately 1.5 cm dorsal to the eyes. Piglets were allowed to stabilize for 1 h after surgery before any CBF measurements were acquired. This delay was also sufficient to minimize drift artifacts in the TR measurements due to temperature changes. 32 Cerebral blood flow was measured with both the TR and CW techniques, sequentially ͑separated by 5 to 10 min͒ during normocapnia, hypercapnia, and temporary carotid occlusion. This required swapping the probes, which had the same outer diameter, from the two systems between measurements. For each animal, three sets of TR and CW data were acquired during normocapnia, two sets during hypercapnia, and a final two sets after vascular occlusion. The arterial ICG concentration curve was measured by attaching the dye densitometer probe to a forefoot. The bolus of ICG was 0.05 mg dissolved in 0.5-ml sterile water. Tissue concentration curves were determined from reflectance data acquired continually for 70 s at a sampling interval of 400 ms for the TR system and 200 ms for the CW apparatus. For the TR measurements, the initial count rate was adjusted to 800 kHz ͑1% of the laser repetition rate͒. Each experiment was completed within 4 h.
Statistical Analysis
All data are presented as meanϮ SE unless otherwise stated. Statistical analyses were conducted using SPSS 16.0 ͑SPSS, Chicago, Illinois͒ and statistical significance was defined as p Ͻ 0.05. One-way analysis of variance ͑ANOVA͒ with post hoc analysis by Tukey's honestly significant difference ͑HSD͒ tests was used to assess any changes in a physiological parameter between the three conditions ͑normocapnia, hypercapnia, and carotid occlusion͒. A two-way repeated-measures ANOVA was used to assess differences in each of the nearinfrared measurements ͑CBF, CBV, and DP͒ with condition as the within-subjects variable and NIR technique as the between-subjects variable.
A common regression analysis could not be used to determine the statistical significance of correlations between CBF measurements from the two optical techniques, because multiple measurements were acquired from each animal. Instead, a variation of the generalized estimating equation technique was utilized. 34, 35 First, a linear fit was applied to the data from each piglet individually. Second, a significant correlation was tested by using a t-test to compare the average of the distribution of slopes against the null hypothesis ͑i.e., slope= 0͒. Finally, the distribution of slopes was compared to a slope of 1 to determine the agreement with the line of identity. BlandAltman analysis was used to assess the agreement between CBF measurements from the two techniques. 36 
Results
Cerebral blood flow measurements were acquired in six piglets less than 24 h of age ͑mean weight= 1.52Ϯ 0.06 kg, five females and one male͒. Average physiological parameters during normocapnia, hypercapnia, and carotid occlusion are summarized in Table 1 . As expected, PaCO 2 was significantly different between normocapnia and hypercapnia ͑p Ͻ 0.005͒. The mean PaCO 2 value during carotid occlusion was similar to the mean hypercapnic value, since carotid occlusion was performed immediately following hypercapnia. No statistically significant differences were observed for any of the other physiological parameters. In total, 42 sets of TR-and CW-NIRS ICG measurements were completed. Two sets were removed because the arterial ICG concentration curves were not properly transferred from the DDG to the personal computer.
An example IRF is shown in Fig. 1͑a͒ . The FWHM characterizing the dispersion in the TR system was 0.490Ϯ 0.001 ns. The measured a and s Ј values of the tissue-mimicking phantom were 0.118Ϯ 0.001 cm −1 and 8.12Ϯ 0.13 cm −1 , respectively ͑meanϮ SD͒. Two TPSFs measured from one piglet are shown in Fig. 1͑b͒ , each acquired over a 400-ms integration period. One was acquired at baseline, and the other corresponds to the largest reduction in the measured light reflectance following an injection of ICG. These data illustrate the typical change in amplitude and shape of the TPSF due to the passage of ICG through brain. The optical properties of the piglet head were determined Table 2 for normocapnic, hypercapnic, and carotid occlusion conditions. A repeated-measures ANOVA determined that the DP values from the two techniques were significantly different across the three conditions ͑F 1,10 = 29.8, p Ͻ 0.001, powerϾ 0.99͒, however, no significant interactions were observed between DP and condition with either technique, indicating that DP did not change significantly between conditions. Figure 2 displays two sets of ICG concentration curves measured by the TR and CW-NIRS techniques. In this example, the peak tissue ICG concentration measured by CW-NIRS was higher than that measured by the TR system. This difference translated into a higher CBF estimate determined by CW-NIRS ͑82 ml/ 100 g / min͒ than by the TR method ͑61 ml/ 100 g / min͒. The contrast-to-noise ratio ͑CNR͒ for each NIR approach was calculated as the maximum signal change following ICG injection divided by the standard deviation of the background signal. The mean CNR was 116Ϯ 26 for the TR data, and 186Ϯ 26 for the CW-NIRS data ͑the latter was adjusted to account for the shorter integration time͒. These values were calculated from ICG concentration curves acquired during normocapnia, and the mean CNR was statistically greater for the CW data compared to the TR data ͑p Ͻ 0.01͒.
The correlation plot between CBF measurements from the two techniques and the corresponding Bland-Altman plot are shown in Fig. 3 . The average slope, intercept, and R 2 value from the individual regression analyses were 0.79Ϯ 0.06, −2.2Ϯ 2.5 ml/ 100 g / min, and 0.810Ϯ 0.088, respectively. The average intercept was not significantly different from zero. The average slope was significantly different from the null ͑p Ͻ 0.001͒, indicating that a correlation existed between the two sets of CBF measurements. However, the slope was also significantly different from unity ͑p Ͻ 0.05͒, indicating a difference between CBF measurements from the techniques as flow increased. This discrepancy was reflected in a significant main effect between techniques determined by the repeatedmeasures ANOVA ͑F 1,10 = 5.78, p Ͻ 0.05, powerϾ 0.55͒ and in the mean CBF difference ͑16.1 ml/ 100 g / min͒ revealed by the Bland-Altman analysis ͑p Ͻ 0.001͒.
The correlation plot between CBV measurements from the two techniques is shown in Fig. 4 , along with the corresponding Bland-Altman plot. The average slope, intercept, and R 2 from the individual regression analyses were 0.38Ϯ 0.16, 1.72Ϯ 0.65 ml/ 100 g, and 0.33Ϯ 0.13, respectively. Similar to the CBF results, the average slope was significantly greater than the null ͑p Ͻ 0.05͒ and less than unity ͑p Ͻ 0.025͒. A significant main effect between NIR techniques was found ͑F 1,10 = 6.19, p Ͻ 0.05, powerϾ 0.60͒, and the mean CBV difference between techniques revealed by the Bland-Altman analysis ͑1.7 ml/ 100 g͒ was also significant ͑p Ͻ 0.001͒. Figure 5 illustrates the predicted error in ⌬ a max caused by altering the FWHM of the IRF. As expected, 23 the results
show that the accuracy of ⌬ a max is very sensitive to instrument dispersion. An underestimation of 10% in the FWHM caused ⌬ a max to be overestimated by 11.6%, while a 10% overestimation caused ⌬ a max to be underestimated by 20%.
The error analysis showed that the accuracy of ⌬ a max was insensitive to timing uncertainties and nonlinearities within the characterized range of the TR system. 32 A 21-ps error in the position of the IRF caused only a 2.2% error in ⌬ a max . Also, the subtle change in the shape of the IRFs acquired at Fig. 2 Representative tissue ͑solid line͒ and arterial blood ͑dotted line͒ ICG concentration curves measured simultaneously following an intravenous bolus injection of ICG ͑0.1 mg/ ml͒ using ͑a͒ the TR-NIR system and ͑b͒ the CW-NIRS apparatus. Both sets of curves were acquired sequentially from the same animal with a delay of approximately 10 min between ICG injections. For viewing purposes, the tissue concentration curves were scaled by a factor of 30 to compensate for the small blood volume in the brain. count rates 800 and 400 kHz resulted in only a −1.1% error in ⌬ a max .
Discussion
Interest in biomedical applications of time-resolved NIR techniques has increased recently thanks in part to the development of relatively inexpensive high quality components, including pulsed diode lasers and compact dynode photomultiplier tubes. The main advantages of TR-NIR are the ability to quantify absorption and scattering properties, and improved depth discrimination using either time gating or higher temporal moments. 15, 18, 37 Using the latter approach, the shape of brain ICG concentration curves was shown to reflect the extent of vessel stenosis in stroke patients, demonstrating the sensitivity of TR-NIR to cerebral perfusion. 20 The focus of the current work was to build on these promising findings by developing a method for extracting quantitative CBF measurements from time-resolved ICG bolus-tracking data. Such a technique would be beneficial to the management of neurological emergencies, such as subarachnoid hemorrhage and traumatic brain injury, since ensuring adequate CBF during intensive care is critical for avoiding secondary brain injury. 38 Our ICG bolus-tracking approach for measuring CBF is based on the same principles underlying contrast-enhanced MRI and CT techniques. 39 The deconvolution method used to determine CBF from the dynamic arterial and tissue concentration curves has been validated in a CT perfusion study by comparison to blood flow measurements obtained by radiolabeled microspheres. 11 We have also reported good agreement between CBF measurements acquired by CT perfusion and CW-NIRS in two previous studies involving newborn piglets. 9, 10 In the current study, a strong correlation ͑R 2 = 0.81͒ was observed between CBF measurements obtained by TR-and CW-NIRS methods over a flow range from 20 to 100 ml/ 100 g / min. The time-resolved approach also produced tissue ICG concentration curves with a high CNR ͑Fig. 2͒, although, as expected, the CNR was higher for CW-NIRS. These results demonstrate that TR-NIR, combined with the bolus-tracking method, has the sensitivity to measure CBF over a clinically relevant range. However, CBF measurements from the two NIR techniques were not in perfect agreement, as indicated by the average correlation slope ͑0.79Ϯ 0.06͒ and the bias revealed by Bland-Altman analysis ͑16.1 ml/ 100 g / min͒. A similar pattern was observed by comparing CBV measurements acquired by the two techniques. In this case, the correlation was only moderate and the average slope farther from unity. The poorer performance of the CBV comparison is partly explained by the greater variability in the measurements from both techniques and the smaller range of CBV values compared to the CBF range.
There are a number of potential sources of error with both techniques that could contribute to the discrepancy between the hemodynamic measurements. The continuous-wave method is clearly the simpler of the two techniques, but there are factors that can reduce its accuracy. The first consideration is the suitability of characterizing light attenuation by the modified Beer-Lambert law, since attenuation is a function of both absorption and scatter. However, it is reasonable to assume that the change in attenuation is linearly proportional to the change in absorption, provided the latter is relatively small: 27 the amount of ICG injected was limited to 0.05 mg, resulting in a maximum change in the absorption coefficient of approximately 0.05 cm −1 . A second concern is errors in the differential path length measurements obtained by seconddifferential analysis. Matcher, Cope, and Delpy 27 demonstrated an excellent agreement between DP measurements obtained by this approach and values obtained with a Streak camera in a tissue-mimicking phantom. We determined the DP using the 840-nm water feature, which is close to the maximum absorption wavelength of ICG in plasma. The differential path length factor calculated from the average DP and a source-detector distance of 2.7 cm was 3.69Ϯ 0.22, which is in good agreement with a previously reported value of 4.0, also obtained by CW-NIRS in newborn piglets. 26 In both studies, the cerebral water concentration was assumed to be 85% due to the higher water concentration in the newborn brain compared to the adult brain. However, this value reflects gray matter and does not account for the lower water concentration in white matter, which is closer to 76% in piglets. 40 The correct DP could be higher, depending on the proportional contributions of the two brain tissues in the collected reflectance. For example, adjusting DP for a 50/ 50 mixing of gray and white matter would reduce the CW-CBF estimates by approximately 6%. The CBF estimates would be further reduced using the larger time-resolved DP values. However, the corresponding water concentration would be 65%, which is not physiologically possible in a healthy brain.
Given the complexity of the instrumentation, there are a number of factors that can degrade the accuracy of TR-NIR reflectance measurements. Temporal stability can be impaired by instrumental drift and jitter. 23, 41 From a series of instrument response functions acquired over a 3-h period, we found that drift artifacts were negligible, provided the system was allowed a warm-up period of at least one hour. 32 The effects of timing jitter were also quite small: the standard deviation of the temporal position of the IRF from a series of IRFs was 4.3 ps. 32 An error in the position of the IRF as large as 21 ps only caused a 2.2% error in the absorption change. Another common source of error is incorrectly characterizing the amount of dispersion caused by the system ͑i.e., the instrument response function͒. To measure the IRF, we followed previous recommendations and placed a thin piece of matte paper between the emission and detection probes to act as a diffuser. 24, 25 The reasonable agreement between our measurements of the tissue-mimicking phantom's optical properties and the values provided by the manufacturer suggests that the IRF was properly characterized. Figure 5 demonstrates that underestimating ⌬ a max , and conversely CBF, would result from overestimating the FWHM of the IRF. However, this would also lead to an underestimation of the DP, since it is proportional to the difference in mean transit times between the experimental TPSF and the IRF. This scenario would seem unlikely, considering the time-resolved DP measurements are already significantly greater than the continuous-wave DP measurements. In fact, the more common occurrence is to underestimate instrument dispersion by not filling all modes of the detection fiber bundle. 24 It is unlikely that light diffusion in the paper used to measure the IRF would have significant dispersion effects. To test this, we repeated the procedure with a thicker piece of paper, and no change in the shape of the IRF was observed ͑data not shown͒.
To correctly measure the tissue ICG concentration curve, the time-resolved system must be linear over the expected range of photon count rates. Of primary concern are distortions in the shape of the TPSF due to pile-up effects, since the magnitude of this artifact can vary with count rate. To minimize this potential source of error, the initial count rate ͑i.e., 800 kHz͒ was set to 1% of the pulse repetition rate, and the maximum reduction in the count rate was limited to approximately 400 kHz by reducing the amount of ICG injected. Potential effects of distortions in the TPSF were assessed by measuring the IRF at the two extremes ͑400 and 800 kHz͒. The small error in ⌬ a max ͑−1.1%͒ resulting from differences between the two IRFs demonstrated that count-rate dependent distortions were negligible.
There are two plausible explanations for the differences found between the hemodynamic measurements from the two NIR techniques. First, although we were not able to clearly identify a single source of error strong enough to account for the discrepancy, it could be the result of a combination of small errors with both techniques. Examples would include uncertainties in the assumed water concentration required to measure DP by CW-NIRS, or variations between the measured and true IRF of the TR system. A second explanation is that the two techniques are interrogating slightly different brain regions. Intensity measurements by CW-NIRS are known to be more sensitive to tissues immediately below the surface, resulting in CBF measurements that, predominately reflect cortical gray matter. Since the cortex in the piglet brain is approximately 1 cm thick, the increased depth sensitivity of TR-NIR may have resulted in increased signal contributions from subcortical white matter, which has significantly lower blood flow. The DP measurements support this explanation, since the values obtained by the TR technique were greater than those obtained by CW spectroscopy-both in the current study and in previous studies involving piglets. 26, 30 Further evidence for this explanation is provided by the time-of-flight information. Figure 6 shows the change in attenuation following an ICG injection for three time windows: early, middle, and late. Intriguingly, the maximum attenuation change, which is proportional to CBF, was found in the middle time interval, suggesting that photons in this time interval were probing cortical gray matter, while late-arriving photons were interrogating deeper white matter. Note that these attenuation curves were not converted into ICG concentration curves because of the substantial contribution of the IRF to the measured experimental TPSF ͑i.e., time-of-flight data͒. Since the IRF of our system was fairly wide, approximately 0.5 ns, a deconvolution routine would be required to extract the true time-of-flight data. In future experiments, the difference in depth sensitivity between the two NIR techniques could be investigated using an imaging technique to acquire maps of CBF combined with modeling procedures to determine the light propagation paths.
In summary, this is the first study to attempt a quantitative measure of cerebral blood flow using time-correlated singlephoton technology. The technique produced ICG concentration curves with high CNR, and could accurately track changes in CBF caused by either elevating arterial blood CO 2 or impeding blood flow in the common carotids. A strong positive correlation between CBF measurements from the TR-NIR technique and a previously validated CW-NIRS technique was found. Future work will include further validation in older animals with non-negligible extracerebral layers and adaptation to human studies. These applications will require incorporating a multilayered model 43 or using time-of-flight data to improve depth sensitivity. Challenges facing these approaches include increased complexity of a layered model, signal contamination from ICG fluorescence at late arrival times, 44 and errors in time-of-flight measurements due to the contribution of the IRF. The CBF measurements could also be combined with measurements of tissue oxygenation-derived from reflectance measurements at wavelengths sensitive to oxy-and deoxyhemoglobin concentrations-to determine the cerebral metabolic rate of oxygen. 35, 45 
